Optimizing Deep Brain Stimulation to Improve Vision in Parkinson's
Official title: Optimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease
Run by VA Office of Research and Development · NCT06857851 · Data updated 2026-11-12
This study tests how adjusting deep brain stimulation in the subthalamic region can improve eye alignment and depth perception in people with Parkinson's disease.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | September 30, 2029 |
| Study ends | October 1, 2029 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT06857851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson's disease who have bilateral STN DBS and compatible imaging availability, at Hoehn and Yahr stages 2-4 off medication with stable medication and DBS settings.
✕Probably not a fit
Patients without measurable vergence or strabismus issues or those not meeting imaging criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project examines how different DBS locations and settings in the subthalamic region affect vergence and strabismus in Parkinson's patients. researchers will combine patient-specific DBS models with high-resolution eye-tracking to identify stimulation locations and parameters that improve binocular coordination while maintaining motor benefits. The study uses existing DBS patients with bilateral STN implants and requires imaging availability to map brain targets. Findings could guide personalized DBS programming to help with vision-related symptoms alongside motor control. No intervention beyond current DBS management is prescribed in this observational framework.
Why it matters
Potential benefit: If successful, patients could experience better eye coordination and reduced double vision without sacrificing motor symptom control.
How similar studies have gone: Prior DBS research has shown variable effects on eye movements; this study explores a targeted adaptation of DBS for vision, with mixed but promising prior signals.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parkinson's disease with bilateral STN DBS * Availability of pre-operative MR images (with a T1-weighted, gradient-echo sequence) and ability to get post-operative MRI or CT scans * Hoehn and Yahr stage 2-4 when off medication, and a stable antiparkinsonian medication regimen and DBS parameter settings Exclusion Criteria: * Previous surgical therapy for Parkinson's disease (other than DBS) * Dementia * Clinically significant untreated depression or anxiety * Clinical features suggestive of atypical parkinsonism
Where it's running
-
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Aasef G. Shaikh, MD PhD — Louis Stokes VA Medical Center, Cleveland, OH
- Study coordinator: Aasef G Shaikh, MD PhD
- Email: Aasef.Shaikh@va.gov
- Phone: (216) 791-3800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Real-world experiences of Inbrija for Parkinson's OFF episodes
This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Test of RO7568282 in early Parkinson's disease
This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.